Recommandations Bourse de Paris | Compartiment C | Page 2
Recommandations des analystes professionnels
- Acheter
- Renforcer
- Conserver
- Alléger
- Vendre
Libellé | Reco. | Der. Cours* | Obj. Cours** | Potentiel | Nb. Analystes. | Bna. 2024 | Rend. 2024*** | Per. 2024 | Per. 2023 |
|---|---|---|---|---|---|---|---|---|---|
| DAMARTEX | Conserver | 3.110 | 4.500 | +44.695% | 1(+0) | -1.570 EUR | - | 0.000 | 0.000 |
| DMS | Acheter | 1.010 | 2.200 | +117.822% | 1(+0) | 0.080 EUR | - | 14.125 | 56.500 |
| EGIDE | Conserver | 0.594 | 0.950 | +59.933% | 1(+0) | -0.100 EUR | - | 0.000 | 0.000 |
| EKINOPS | Acheter | 3.515 | 5.200 | +47.937% | 5(+0) | 0.120 EUR | - | 29.208 | 26.962 |
| ENCRES DUBUIT | Renforcer | 3.000 | 3.500 | +16.667% | 1(+0) | -0.130 EUR | - | 0.000 | 0.000 |
| FERMENTALG | Acheter | 0.592 | 1.000 | +68.919% | 1(+0) | -0.220 EUR | - | 0.000 | 0.000 |
| FLEURY MICHON | Conserver | 21.200 | 21.750 | +2.594% | 2(+0) | 4.394 EUR | 5.769% | 4.734 | 5.355 |
| GENEURO | Acheter | 1.435 | 4.000 | +178.746% | 2(+0) | 0.030 EUR | - | 48.167 | 0.000 |
| GENSIGHT BIOLOGICS | Alléger | 0.410 | 0.400 | Atteint | 1(+0) | -0.570 EUR | - | 0.000 | 0.000 |
| GROUPE LDLC | Renforcer | 16.780 | 20.000 | +19.190% | 2(+0) | 1.030 EUR | 3.140% | 16.544 | 79.256 |
| GT BIOPHARMA | Acheter | 0.550 | 4.638 | +743.195% | 1(+0) | -0.334 EUR | - | 0.000 | 0.000 |
| GUILLEMOT CORP. | Acheter | 5.200 | 7.300 | +40.385% | 2(+0) | 0.425 EUR | 0.772% | 12.188 | 28.778 |
| HAULOTTE GROUP | Renforcer | 2.300 | 2.563 | +11.413% | 4(+0) | 0.550 EUR | 2.652% | 4.036 | 258.983 |
| HERIGE | Acheter | 32.300 | 47.000 | +45.511% | 2(+0) | 8.729 EUR | 2.923% | 3.723 | 7.350 |
| HIGH CO | Conserver | 2.940 | 3.150 | +7.143% | 4(+0) | 0.275 EUR | 6.920% | 10.509 | 5.558 |
| HIPAY GROUP | Acheter | 8.000 | 18.000 | +125.000% | 1(+0) | 0.740 EUR | - | 10.865 | 18.273 |
| HOPSCOTCH GRP | Acheter | 21.300 | 29.300 | +37.559% | 2(+0) | 2.420 EUR | 2.304% | 8.967 | 11.573 |
| INNELEC MULTIMEDIA | Acheter | 6.480 | 11.050 | +70.525% | 2(+0) | 0.435 EUR | 7.874% | 14.598 | 15.119 |
| IT LINK | Acheter | 31.300 | 40.000 | +27.796% | 1(+0) | 2.420 EUR | 1.549% | 12.893 | 15.838 |
| LACROIX | Acheter | 23.400 | 29.000 | +23.932% | 2(+0) | 2.125 EUR | 2.860% | 11.435 | 27.000 |
| LEBON | Acheter | 94.800 | 146.000 | +54.008% | 1(+0) | 7.670 EUR | 4.228% | 12.334 | 12.318 |
| MAAT PHARMA | Acheter | 8.820 | 15.625 | +77.154% | 4(+0) | -2.490 EUR | - | 0.000 | 0.000 |
| MAUNA KEA TECHNOLOGIES | Acheter | 0.388 | 1.540 | +296.907% | 3(+0) | -0.134 EUR | - | 0.000 | 0.000 |
Source : Factset JCF
* Cours de clôture référence
** Objectif de cours médian à 100 jours
*** Rendement du dividende sur l'année fiscale à venir
Mis à jour le 22.04.24